Archer Materials Limited (AU:AXE)
ASX:AXE
Want to see AU:AXE full AI Analyst Report?
Top Page
Archer Materials
(Sydney:AXE)
Select Model
Select Model
Rating:42Neutral
Price Target:
AU$0.32
▼(-9.43% Downside)
Action:ReiteratedDate:04/02/26
The score is weighed down primarily by weak financial performance (declining revenue, persistent losses, negative ROE, and pressured cash flow) and bearish technicals (price below major moving averages with negative MACD and low RSI). Valuation provides little offset because the negative P/E reflects unprofitable operations and no dividend support is indicated.
Positive Factors
Low leverage / conservative capital structure
Extremely low debt-to-equity (0.0009) provides a conservative capital structure that preserves financial flexibility for a high-R&D semiconductor developer. Low leverage reduces insolvency risk and interest burden, allowing the business to weather development cycles and pursue partnerships without heavy fixed financing costs.
Negative Factors
Declining revenue
Revenue fell roughly 10.98% in the latest year, indicating weakening commercial traction. For a capital- and development-intensive quantum semiconductor firm, declining sales reduce operating runway, amplify funding needs and may delay product rollouts or scale-up plans absent sustained new revenue streams.
Read all positive and negative factors
Positive Factors
Negative Factors
Low leverage / conservative capital structure
Extremely low debt-to-equity (0.0009) provides a conservative capital structure that preserves financial flexibility for a high-R&D semiconductor developer. Low leverage reduces insolvency risk and interest burden, allowing the business to weather development cycles and pursue partnerships without heavy fixed financing costs.
Read all positive factors
Archer Materials (AXE) vs. iShares MSCI Australia ETF (EWA)
Market Cap
AU$72.63M
Dividend YieldN/A
Average Volume (3M)299.08K
Price to Earnings (P/E)―
Beta (1Y)0.77
Revenue GrowthN/A
EPS Growth13.49%
CountryAU
Employees8
SectorTechnology
Sector Strength88
IndustrySemiconductors
Share Statistics
EPS (TTM)-0.01
Shares Outstanding254,847,020
10 Day Avg. Volume127,203
30 Day Avg. Volume299,084
Financial Highlights & Ratios
PEG Ratio-0.17
Price to Book (P/B)3.27
Price to Sales (P/S)26.62
P/FCF Ratio-13.05
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Archer Materials Business Overview & Revenue Model
Company Description
Archer Materials Limited, a technology company, engages in development and commercialization of semiconductor devices, and processor chips related to quantum computing and medical diagnostics in Australia. It primarily focuses on the development o...
How the Company Makes Money
null...
Archer Materials Financial Statement Overview
Summary
Income Statement
35
Negative
Balance Sheet
45
Neutral
Cash Flow
40
Negative
| Breakdown | TTM | Jun 2025 | Jun 2024 | Jun 2023 | Jun 2022 | Jun 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 845.89K | 2.06M | 2.14M | 1.50M | 973.00K | 467.66K |
| Gross Profit | 795.39K | 2.06M | 2.14M | -53.74K | 922.59K | 435.36K |
| EBITDA | -7.74M | -6.94M | -5.11M | -8.66M | -14.97M | -3.24M |
| Net Income | -5.55M | -6.97M | -4.80M | -9.05M | -14.12M | -7.84M |
Balance Sheet | ||||||
| Total Assets | 14.87M | 17.47M | 22.89M | 27.21M | 30.17M | 19.69M |
| Cash, Cash Equivalents and Short-Term Investments | 10.32M | 13.82M | 18.78M | 24.19M | 28.17M | 8.93M |
| Total Debt | 6.90K | 14.97K | 109.31K | 9.10K | 19.75K | 30.09K |
| Total Liabilities | 909.76K | 752.16K | 1.09M | 1.21M | 746.23K | 732.71K |
| Stockholders Equity | 13.96M | 16.72M | 21.80M | 26.00M | 29.42M | 18.96M |
Cash Flow | ||||||
| Free Cash Flow | -6.47M | -4.19M | -4.99M | -3.21M | -4.44M | -2.32M |
| Operating Cash Flow | -6.45M | -4.19M | -4.79M | -3.03M | -4.30M | -2.22M |
| Investing Cash Flow | 9.38M | 4.11M | 6.98M | 2.31M | -94.83K | -262.25K |
| Financing Cash Flow | -18.73K | -96.30K | -115.82K | 64.90K | 24.62M | 606.22K |
Archer Materials Technical Analysis
Positive
0.35
Price Trends
0.34
Negative
0.36
Negative
0.34
Negative
Market Momentum
>-0.01
Negative
52.63
Neutral
68.89
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AU:AXE, the sentiment is Positive. The current price of 0.35 is above the 20-day moving average (MA) of 0.32, above the 50-day MA of 0.34, and above the 200-day MA of 0.34, indicating a neutral trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 52.63 is Neutral, neither overbought nor oversold. The STOCH value of 68.89 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AU:AXE.
Archer Materials Peers Comparison
UnderperformOutperform
Sector (61)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
49 Neutral | AU$932.95M | -8.87 | -57.61% | ― | 508.63% | -6.35% | |
48 Neutral | AU$349.39M | -11.70 | -89.98% | ― | 386.28% | 21.47% | |
46 Neutral | AU$36.80M | -1.86 | -99.85% | ― | 2.41% | 23.50% | |
43 Neutral | AU$22.67M | -6.20 | -86.80% | ― | ― | 7.50% | |
42 Neutral | AU$72.63M | -7.24 | -36.17% | ― | ― | 13.49% | |
41 Neutral | AU$1.71B | -32.20 | -27.53% | ― | 64.95% | -31.63% |
* Technology Sector Average
AU:AXE
Archer Materials
0.29
0.01
5.56%
AU:BRN
BrainChip Holdings
0.16
-0.10
-38.00%
AU:BLG
BluGlass
0.24
>-0.01
-2.08%
AU:4DS
4DS Memory
0.01
-0.02
-64.52%
AU:SLX
Silex Systems Limited
6.13
2.98
94.60%
AU:WBT
Weebit Nano Ltd.
4.01
2.17
117.34%
Archer Materials Corporate Events
Archer pushes Biochip into beta phase, eyes clinical validation and scale-up
Apr 7, 2026
Archer Materials has moved its Biochip program from an alpha prototype to the development of a beta prototype designed for external use and pre-clinical validation. The system will integrate a silicon-based sensing chip with Archer’s proprie...
Archer moves quantum fraud detection project into simulation phase
Mar 17, 2026
Archer Materials has advanced its quantum machine learning research program, selecting and preprocessing a publicly available dataset of more than 280,000 bank transactions to build a quantum model for financial fraud detection. By adapting the da...
Archer Materials to Present 1H FY26 Update on Quantum Chip Progress
Mar 3, 2026
Archer Materials has released a presentation for its first-half FY26 update, to be delivered via a webinar led by Chief Executive Officer Simon Ruffell. The session, scheduled for today and including a QA component, signals ongoing engagement with...
Archer Materials Marks Quantum Readout Breakthrough and Advances Biochip Strategy
Feb 25, 2026
Archer Materials reported 1H FY26 progress marked by a major technical breakthrough in its carbon-based quantum computing program, achieving on-chip electrical readout of quantum states via EDMR and SET devices and validating CMOS-compatible, wafe...
Archer Materials Releases Q2 FY26 Investor Webinar Presentation
Jan 29, 2026
Archer Materials has released the presentation that its CEO Simon Ruffell will deliver during an investor webinar scheduled for 11:00am AEDT on 29 January 2026, which will be followed by a QA session. The event underlines the company’s ongoi...
Archer Materials Advances Quantum Qubit and Biochip Milestones, Expands Strategic Partnerships
Jan 29, 2026
In the December quarter of FY26, Archer Materials reported significant technical and strategic progress across its core quantum and biochip programs, including improved quantum state readout for its carbon-based qubit materials, successful synthes...
Archer Materials Schedules Investor Webinar for December Quarter Update
Jan 21, 2026
Archer Materials has announced it will host an investor webinar to deliver its quarterly update for the period ended 31 December 2025, with CEO Simon Ruffell presenting and taking questions from participants. The event underscores the company̵...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.